Abstract

Human cytomegalovirus (HCMV) is a widespread pathogen that in immunocompromised hosts can cause life-threatening disease. Studying HCMV-exposed monocyte-derived dendritic cells by single-cell RNA sequencing, we observe that most cells are entered by the virus, whereas less than 30% of them initiate viral gene expression. Increased viral gene expression is associated with activation of the stimulator of interferon genes (STING) that usually induces anti-viral interferon responses, and with the induction of several pro- (RHOB, HSP1A1, DNAJB1) and anti-viral (RNF213, TNFSF10, IFI16) genes. Upon progression of infection, interferon-beta but not interferon-lambda transcription is inhibited. Similarly, interferon-stimulated gene expression is initially induced and then shut off, thus further promoting productive infection. Monocyte-derived dendritic cells are composed of 3 subsets, with one being especially susceptible to HCMV. In conclusion, HCMV permissiveness of monocyte-derived dendritic cells depends on complex interactions between virus sensing, regulation of the interferon response, and viral gene expression.

Human cytomegalovirus (HCMV) is a ubiquitous pathogen associated with morbidity and mortality in the immunocompromised or immunonaive context. Here the authors show that HCMV exploits STING signalling and subverts the interferon response to support infection of monocyte derive dendritic cells.

Details

Title
Human cytomegalovirus exploits STING signaling and counteracts IFN/ISG induction to facilitate infection of dendritic cells
Author
Costa, Bibiana 1   VIAFID ORCID Logo  ; Becker, Jennifer 1   VIAFID ORCID Logo  ; Krammer, Tobias 2   VIAFID ORCID Logo  ; Mulenge, Felix 1   VIAFID ORCID Logo  ; Durán, Verónica 1 ; Pavlou, Andreas 1 ; Gern, Olivia Luise 1   VIAFID ORCID Logo  ; Chu, Xiaojing 3   VIAFID ORCID Logo  ; Li, Yang 4   VIAFID ORCID Logo  ; Čičin-Šain, Luka 5   VIAFID ORCID Logo  ; Eiz-Vesper, Britta 6   VIAFID ORCID Logo  ; Messerle, Martin 7   VIAFID ORCID Logo  ; Dölken, Lars 8   VIAFID ORCID Logo  ; Saliba, Antoine-Emmanuel 9   VIAFID ORCID Logo  ; Erhard, Florian 10   VIAFID ORCID Logo  ; Kalinke, Ulrich 11   VIAFID ORCID Logo 

 a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
 Helmholtz-Centre for Infection Research (HZI), Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany (GRID:grid.498164.6) 
 Centre for Individualised Infection Medicine (CiiM) & TWINCORE, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Department of Computational Biology for Individualised Medicine, Hannover, Germany (GRID:grid.512472.7) 
 Centre for Individualised Infection Medicine (CiiM) & TWINCORE, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Department of Computational Biology for Individualised Medicine, Hannover, Germany (GRID:grid.512472.7); Radboud University Medical Center, Department of Internal Medicine and Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands (GRID:grid.461760.2) 
 Helmholtz Centre for Infection Research, Institute for Immune Aging and Chronic Infection, Braunschweig, Germany (GRID:grid.7490.a) (ISNI:0000 0001 2238 295X) 
 Hannover Medical School, Institute for Transfusion Medicine and Transplant Engineering, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
 Hannover Medical School, Institute of Virology, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
 University of Würzburg, Institute for Virology and Immunobiology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658) 
 Helmholtz-Centre for Infection Research (HZI), Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany (GRID:grid.498164.6); Institute of Molecular Infection Biology (IMIB), University of Würzburg, Faculty of Medicine, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658) 
10  University of Würzburg, Institute for Virology and Immunobiology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Regensburg, Faculty for Informatics and Data Science, Regensburg, Germany (GRID:grid.7727.5) (ISNI:0000 0001 2190 5763) 
11  a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Hannover Medical School, Cluster of Excellence - Resolving Infection Susceptibility (RESIST, EXC 2155), Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
Pages
1745
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2931863926
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.